Clinical correlates and pharmacological management of Asian patients with concomitant diabetes mellitus and heart failure
- PMID: 29383639
- DOI: 10.1007/s10741-018-9672-5
Clinical correlates and pharmacological management of Asian patients with concomitant diabetes mellitus and heart failure
Abstract
Asia is the center of convergence of the twin epidemics of diabetes mellitus (DM) and heart failure (HF). The regional and ethnic diversity across Asia, along with a high prevalence of a young, lean diabetic phenotype, emphasizes the importance of targeted public health strategies that address the unique needs of Asian patients with DM and HF. This review discusses the epidemiology, clinical correlates, pharmacological management, and outcomes of Asian patients with concomitant DM and HF.
Keywords: Asia; Diabetes mellitus; Heart failure; Outcomes; Pharmacotherapy.
Similar articles
-
Multi-ethnic comparisons of diabetes in heart failure with reduced ejection fraction: insights from the HF-ACTION trial and the ASIAN-HF registry.Eur J Heart Fail. 2018 Sep;20(9):1281-1289. doi: 10.1002/ejhf.1223. Epub 2018 Jun 26. Eur J Heart Fail. 2018. PMID: 29943890 Clinical Trial.
-
Heart failure and diabetes mellitus: epidemiology and management of an alarming association.J Card Fail. 2008 Sep;14(7):615-25. doi: 10.1016/j.cardfail.2008.04.001. Epub 2008 May 27. J Card Fail. 2008. PMID: 18722328 Review.
-
Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy.Am J Cardiol. 2007 Feb 19;99(4A):113B-132B. doi: 10.1016/j.amjcard.2006.11.013. Epub 2006 Dec 22. Am J Cardiol. 2007. PMID: 17307064 Review.
-
Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure.JACC Heart Fail. 2015 Feb;3(2):136-45. doi: 10.1016/j.jchf.2014.08.004. JACC Heart Fail. 2015. PMID: 25660838 Review.
-
Concomitant diabetes mellitus and heart failure.Curr Probl Cardiol. 2015 Jan;40(1):7-43. doi: 10.1016/j.cpcardiol.2014.09.002. Epub 2014 Sep 6. Curr Probl Cardiol. 2015. PMID: 25499908 Review.
Cited by
-
Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction.Front Endocrinol (Lausanne). 2020 Jul 10;11:448. doi: 10.3389/fendo.2020.00448. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32754118 Free PMC article.
-
Association of D-dimer to albumin ratio with adverse cardiovascular outcomes in ischaemic heart failure patients with diabetes mellitus: a retrospective cohort study.BMJ Open. 2024 Jan 22;14(1):e078013. doi: 10.1136/bmjopen-2023-078013. BMJ Open. 2024. PMID: 38253454 Free PMC article.
-
Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway.Cancer Cell Int. 2019 Jan 11;19:13. doi: 10.1186/s12935-019-0732-2. eCollection 2019. Cancer Cell Int. 2019. PMID: 30651718 Free PMC article.
-
Monocyte to high-density lipoprotein cholesterol ratio predicts poor outcomes in ischaemic heart failure patients combined with diabetes: a retrospective study.Eur J Med Res. 2023 Nov 8;28(1):493. doi: 10.1186/s40001-023-01451-6. Eur J Med Res. 2023. PMID: 37941037 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous